Skip to content

Mentalization-Based Treatment with and without Competitive Memory Training for patients with borderline personality disorder: randomnized controlled trial

Mentalization-Based Treatment with and without Competitive Memory Training for patients with borderline personality disorder: randomnized controlled trial - nvt

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON39537
Enrollment
Unknown
Registered
2013-01-18
Start date
2013-10-18
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

borderline

Interventions

Patients will receive either MBT + music therapy, or MBT + COMET.

Sponsors

Stichting Rivierduinen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients are registered with the Rivierduinen care program Personality Disorders Aged between 18 and 65 years Confirmation of the primary diagnosis of borderline personality disorder using the international personality disorder examination(IPDE) for DSM-IV BPDSI-IV score bigger than 20 informed consent

Exclusion criteria

Exclusion criteria: Insufficient command of the Dutch language Severe comorbid psychopathology such as: psychotic disorders(except short, reactive psychotic episodes, that can be part of the clinical picture of BPD), bipolar disorder, dissociative identity disorder, antisocial personality disorder, attention deficit hyperactivity disorder, addiction of such severity that clinical detoxification is indicated (after which entering treatment is possible), psychiatric disorders secondary to medical conditions and mental retardation. Comorbid axis 1 and axis 2 disorders are allowed, as is medication use. Simultaneous participation in another specific psychiatric treatment, except medication.

Design outcomes

Primary

MeasureTime frame
The primary outcome measure is the frequency and severity of borderline personality symptomatology as assessed with the Borderline Personality Disorder Severity Index (BPDSI-IV), a semi-structured interview.

Secondary

MeasureTime frame
A secondary aim is to investigate whether this enhanced effectiveness is indeed mediated by changes in self-esteem and/or changes in a bias for negative emotional information. Further it is tested whether a variation in the oxytocin receptor gene moderates the outcomes.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)